5-Benzyloxytryptamine
5-Benzyloxytryptamine (5-BT) is a selective partial agonist for 5-hydroxytryptamine 1D/1B (5-HT1D/1B) receptors with an IC50 value of 40 nM for bovine caudate 5-HT1D and reduced affinity for other receptors (5-HT2 IC50>470 nM) . 5-Benzyloxytryptamine inhibits adenylate cyclase to decrease neurotransmitter release and downregulate cAMP signaling. 5-Benzyloxytryptamine is promising for research of neurotransmitter imbalance-related disorders like migraine[1].
Product Specifications
CAS Number
20776-45-8
Product Name Alternative
5-BT
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
5-HT Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
NCCC1=CNC2=CC=C(OCC3=CC=CC=C3)C=C12
Molecular Formula
C17H18N2O
Molecular Weight
266.34
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Peroutka SJ, et al. 5-benzyloxytryptamine: a relatively selective 5-hydroxytryptamine 1D/1B agent. Life Sci. 1991;49 (6) :409-18.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
5-HT1 Receptor
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
TARS2 sgRNA CRISPR Lentivector (Human) (Target 1)
SQSTM1/p62 (Phospho Ser349) (12P2) Rabbit Monoclonal Antibody